November 15, 2012 By Joseph P. Farrell

Yesterday I blogged about the possibilities opened up by recent Japanese experiments that have successfully produced egg cells from stem cells, and about the implications these emerging technologies spell for what is increasingly looking to be a transhumanist future. There I noted that my co-author Scott de Hart and I argued in our book Transhumanism: A Grimoire of Alchemical Agendas, that much of what the world calls "transhumanism" is really not all that modern a phenomenon, but merely an update of an old, and quintessentially alchemical agenda.

One of the things that alchemical texts spoke rather anachronistically about was the production of a homunculus or artificial human in a "flask," or test tube if you will. And as I detailed in an earlier book The Philosophers' Stone, in some alchemical texts, the celebrated Philosophers' Stone is referred to as an elixir, which can prolong life, heal diseases, or elevate human consciousness. Indeed, Dr. de Hart and I pointed out in Transhumanism that DARPA (Defense Advance Research Projects Agency) is, in effect, looking for precisely that: a universal vaccine applicable against all possible diseases.

Now there is this very interesting development in Europe:

Genetically Modified Humans? New Gene-Altering Drug Paves Way for Mass Modification

Ponder that one very carefully: a drug that modifies genetic defects. Indeed, the article itself alludes to the danger:

"While the drug is only meant to be given to 1 or 2 out of every million people, it paves way for further experimentation into the field of biotechnology and human alteration. Soon, doctors may be giving out drugs to treat any ‘defects’ in genes, whether it be for the so-called ‘fat’ gene or another instance where a damaged gene is present. It could even apply to purported ‘criminal’ genes that are said to predict an individual’s future ‘life of crime’.  It may sound crazy, but scientists are already making even more serious moves that will alter or ‘create’ humankind."

The question is, against what control group do we measure a "defect"? Who, really, is doing the defining of what that defect is? and more importantly, what is to be "done" about it? What is it was a "defect" that produces human genius, say, in a Nikola Tesla, or a Mozart, or a Rembrandt? Is this defect to be modified?

And while we're at it, what sorts of scientific studies have been done concerning the long term, trans-generational effects of the use of such drugs? Notably, the article provides no clue that any such studies have been done, and indeed, it would  be impossible for them to have been done since the technology is only recently emergent, and therefore, trans-generational studies are an impossibility, yet, we rush to deploy such technologies...

...and to do so without any public debate. This, my friends, smacks of an elite with a hidden agenda, and in a hurry...

... See you on the flip side.